Articles

MPOX (Monkeypox): Current Epidemiology, Clinical Manifestations, and Advances in Treatment and Prevention Strategies

/0 Comments/in /by

MPOX (formerly known as monkeypox) has emerged as a significant public health concern in recent years, necessitating a comprehensive understanding of its epidemiology, clinical manifestations, treatment options, prevention strategies, and global health impact. This literature review synthesizes the latest data on the spread and incidence of MPOX, with a focus on geographic distribution, affected populations, and emerging trends in transmission. The clinical presentation of MPOX, including symptoms, disease progression, and complications, is explored, with particular attention to variations across different demographics. Recent advances in the treatment of MPOX are analyzed, covering current antiviral therapies, the role of supportive care, and the potential of new treatments under investigation. Prevention strategies are also examined, highlighting the effectiveness of vaccination efforts, public health measures, and containment and control strategies. The review further considers the broader impact of MPOX on global health, discussing its implications for public health policy and pandemic preparedness. Through this comprehensive analysis, the review aims to provide a robust foundation for understanding MPOX and inform future research, clinical practice, and public health initiatives.

A Review On-SARS-CoV-2 Omicron Variant

/in /by

Severe acute respiratory syndrome – coronavirus 2   is known to cause coronavirus disease (COVID-19), an infectious diseaseThe majority of those exposed to the virus can have moderate respiratory issues and can recover without the need for specific treatment. Some, on the other side, can become gravely unwell and require medication. People over the age of 65, as well as those with existing medical disorders such as cardiovascular risk factors, diabetes, severe pulmonary disease, or cancer, are often more likely to form serious illnesses. COVID-19 can make anyone sick and cause serious illness or even death at any age. The Omicron variation in SARS-CoV-2(severe acute respiratory syndrome coronavirus 2) is the newer coronavirus strain to be identified as a “variant of concern” by the World Health Organization (WHO). Researchers from everywhere in the world, including South Africa, are looking into this variety in order to fully comprehend different aspects of Omicron, but it might take a long time to learn everything there is to know. Due to the scarcity of studies, misinformation about the Omicron variation is spreading around the world, posing a serious threat to healthcare systems and everyday life. Here, we reviewed the finding and characteristics of the Omicron variant, compared the transmission capacity of the Omicron variant with other variants, discussed on the influence of the Omicron variation on the severity of COVID-19 in cancer as well as diabetic patients, and discussed potential strategies and treatments options to avoid and overcome the Omicron variant’s prevalence.